Delbert G. Robinson, MD | Psychiatrist.com

Consensus Statement

Consensus on Monitoring Blood Antipsychotic Levels

May 19, 2020

The quantification of antipsychotic levels in blood, or therapeutic drug monitoring (TDM), could aid clinicians in numerous challenging scenarios. Learn more about using TDM for dosing decisions in this...

Georgios Schoretsanitis, John M. Kane, Christoph U. Correll, et al

Original Research

Early Phase Schizophrenia and LAI

April 23, 2019

Read a study examining if patients in the early phase of schizophrenia would accept LAI antipsychotic treatment.

John M. Kane, Nina R. Schooler, Patricia Marcy, et al

Original Research

The RAISE: First-Episode Psychosis

March 25, 2015

Read an article describing The RAISE Early Treatment Program for First-Episode Psychosis, the background and study design of the program.

John M. Kane, Nina R. Schooler, Patricia Marcy, et al

Article

Time to Treatment Response in First-Episode Schizophrenia: Should Acute Treatment Trials Last Several Months?

September 6, 2011

Juan A. Gallego, Delbert G. Robinson, Serge M. Sevy, et al

Original Research

The Texas Medication Algorithm Project Antipsychotic Algorithm for Schizophrenia: 2006 Update

November 15, 2007

Troy A. Moore, Robert W. Buchanan, Peter F. Buckley, et al

Academic Highlights

New Developments in the Treatment of Schizophrenia.

March 15, 2007

John M. Kane, Stefan Leucht, Stephen R. Marder, et al

Original Research

High-Dose Sertraline Strategy for Nonresponders to Acute Treatment for Obsessive-Compulsive Disorder: A Multicenter Double-Blind Trial

January 16, 2006

Philip T. Ninan, Lorrin M. Koran, Ari Kiev, et al

Article

Recognizing and Managing Antipsychotic Drug Treatment Side Effects in the Elderly

May 1, 2004

Bruce L. Saltz, Delbert G. Robinson, Margaret G. Woerner